SANFORD USD MEDICAL CENTER
- Type
- Teaching hospital
- Where
- Sioux Falls, SD
- Medicare CCN
- 430027
- Received
- $100,311 in 60 records, 2019 ($43,543 general, $56,768 research)
- Source
- CMS Open Payments search ↗
On this site
- Nonprofit contractor: SANFORD USD MEDICAL CENTER Fuzzy (name and state)
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2019 | General payment | 39 | $43,543 |
| 2019 | Research payment | 21 | $56,768 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Incyte Corporation | 14 | $43,496 | 2019 |
| Barco, Inc. | 2 | $21,400 | 2019 |
| W. L. Gore & Associates, Inc. | 6 | $12,399 | 2019 |
| TESARO, Inc. | 1 | $6,012 | 2019 |
| Alexion Pharmaceuticals, Inc. | 2 | $2,500 | 2019 |
| Stryker Corporation | 16 | $2,176 | 2019 |
| ACELL, INC. | 1 | $1,722 | 2019 |
| Osiris Therapeutics Inc. | 1 | $1,000 | 2019 |
| Ethicon US, LLC | 1 | $1,000 | 2019 |
| KLS-Martin L.P. | 1 | $1,000 | 2019 |
| GE HEALTHCARE | 2 | $999 | 2019 |
| Eli Lilly and Company | 1 | $871 | 2019 |
| BioFire Diagnostics, LLC | 1 | $623 | 2019 |
| Linvatec Corporation | 1 | $522 | 2019 |
| SANOFI-AVENTIS U.S. LLC | 1 | $500 | 2019 |
| Merck Sharp & Dohme LLC | 1 | $500 | 2019 |
| AstraZeneca Pharmaceuticals LP | 1 | $500 | 2019 |
| Janssen Pharmaceuticals, Inc | 1 | $500 | 2019 |
| Chiesi USA, Inc. | 1 | $500 | 2019 |
| APPLIED MEDICAL TECHNOLOGY INC | 1 | $500 | 2019 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $499 | 2019 |
| Bio-Rad Laboratories, Inc. | 1 | $408 | 2019 |
| MEDELA LLC | 1 | $400 | 2019 |
| Zimmer Biomet Holdings, Inc. | 1 | $280 | 2019 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Research payment | 21 | $56,768 |
| Gift | 3 | $21,680 |
| Space rental or facility fees (teaching hospital only) | 16 | $16,410 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 17 | $2,584 |
| Education | 2 | $2,345 |
| Grant | 1 | $522 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2019-12-31 | Linvatec Corporation | $522 | Grant | In-kind items and services | LINVATEC ARTHROSCOPY Device, ORTHOPEDIC SURGERY | 2019 | |
| 2019-12-31 | Zimmer Biomet Holdings, Inc. | $280 | Gift | In-kind items and services | Zimmer Biomet Instruments and Implants Device, General | 2019 | |
| 2019-12-13 | W. L. Gore & Associates, Inc. | $4,590 | Research payment | Cash or cash equivalent | Product in Development Device, Devices | Gore Research and Development | 2019 |
| 2019-12-03 | BioFire Diagnostics, LLC | $623 | Education (2 payments) | In-kind items and services | BioFire FilmArray BCID2 IUO 30 Pouch Kit (RFIT-ASY-0146) Device, Clinical Diagnostics | 2019 | |
| 2019-11-19 | Barco, Inc. | $10,700 | Gift | In-kind items and services | COR C F 6MP 30"1H1F 5X00 Device, Diagnostic Imaging | 2019 | |
| 2019-11-19 | Barco, Inc. | $10,700 | Gift | In-kind items and services | COR C F 6MP 30"1H1F 5X00 Device, Diagnostic Imaging | 2019 | |
| 2019-11-08 | W. L. Gore & Associates, Inc. | $405 | Research payment | Cash or cash equivalent | Product in Development Device, Devices | Post-Market Evaluation of the GORE VIABAHN Endoprosthesis with Heparin Bioactive Surface for Treatment of In-Stent Rest | 2019 |
| 2019-10-09 | Stryker Corporation | $498 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | 2019 | |
| 2019-10-09 | Stryker Corporation | $97 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | 2019 | |
| 2019-10-09 | Stryker Corporation | $78 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | 2019 | |
| 2019-10-09 | Stryker Corporation | $23 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | 2019 | |
| 2019-09-26 | TESARO, Inc. | $6,012 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | ZEJULA Drug, ONCOLOGY | 2019 | |
| 2019-08-29 | Incyte Corporation | $1,998 | Research payment | Cash or cash equivalent | A Phase 12 Study of the Safety, Tolerability, and Efficacy of INCB24360 Administered in Combination With Nivolumab in Se | 2019 | |
| 2019-08-27 | Incyte Corporation | $8,196 | Research payment | Cash or cash equivalent | A Phase 12 Study of the Safety, Tolerability, and Efficacy of INCB24360 Administered in Combination With Nivolumab in Se | 2019 | |
| 2019-08-27 | Incyte Corporation | $3,215 | Research payment | Cash or cash equivalent | A Phase 12 Study of the Safety, Tolerability, and Efficacy of INCB24360 Administered in Combination With Nivolumab in Se | 2019 | |
| 2019-08-27 | Incyte Corporation | $1,663 | Research payment | Cash or cash equivalent | A Phase 12 Study of the Safety, Tolerability, and Efficacy of INCB24360 Administered in Combination With Nivolumab in Se | 2019 | |
| 2019-08-27 | Incyte Corporation | $1,550 | Research payment | Cash or cash equivalent | A Phase 12 Study of the Safety, Tolerability, and Efficacy of INCB24360 Administered in Combination With Nivolumab in Se | 2019 | |
| 2019-08-23 | SANOFI-AVENTIS U.S. LLC | $500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | SOLIQUA 100/33 Drug, DIABETES | 2019 | |
| 2019-08-22 | Incyte Corporation | $290 | Research payment | Cash or cash equivalent | A Phase 12 Study of the Safety, Tolerability, and Efficacy of INCB24360 Administered in Combination With Nivolumab in Se | 2019 | |
| 2019-07-16 | Stryker Corporation | $228 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | 2019 | |
| 2019-07-16 | Stryker Corporation | $95 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | 2019 | |
| 2019-07-16 | Stryker Corporation | $44 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | 2019 | |
| 2019-07-16 | Stryker Corporation | $40 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | 2019 | |
| 2019-07-15 | Alexion Pharmaceuticals, Inc. | $1,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Strensiq Drug, Endocrinology | 2019 | |
| 2019-07-09 | AstraZeneca Pharmaceuticals LP | $500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | BYDUREON Drug, Cardiovascular and Metabolism | 2019 | |
| 2019-07-09 | Janssen Pharmaceuticals, Inc | $500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | INVOKANA Drug, Cardiovascular & Metabolism | 2019 | |
| 2019-06-21 | W. L. Gore & Associates, Inc. | $1,560 | Research payment | Cash or cash equivalent | Carotid Stent Device, Devices | GORE Carotid Stent Clinical Study for the treatment of carotid artery stenosis in patients at increased risk for adverse | 2019 |
| 2019-06-21 | APPLIED MEDICAL TECHNOLOGY INC | $500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Bridle Device, Enteral | 2019 | |
| 2019-06-14 | W. L. Gore & Associates, Inc. | $4,320 | Research payment | Cash or cash equivalent | Product in Development Device, Devices | Gore Research and Development | 2019 |
| 2019-06-14 | W. L. Gore & Associates, Inc. | $607 | Research payment | Cash or cash equivalent | Product in Development Device, Devices | Post-Market Evaluation of the GORE VIABAHN Endoprosthesis with Heparin Bioactive Surface for Treatment of In-Stent Rest | 2019 |
| 2019-06-06 | Merck Sharp & Dohme LLC | $500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | JANUVIA Drug, ENDOCRINOLOGY | 2019 | |
| 2019-05-01 | GE HEALTHCARE | $499 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Device, ULTRASOUND | 2019 | |
| 2019-04-12 | Ethicon US, LLC | $1,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | HARMONIC Product Family Device, Energy | 2019 | |
| 2019-04-12 | Stryker Corporation | $279 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | 2019 | |
| 2019-04-12 | Stryker Corporation | $100 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | 2019 | |
| 2019-04-12 | Stryker Corporation | $42 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | 2019 | |
| 2019-04-12 | Stryker Corporation | $13 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | 2019 | |
| 2019-03-29 | Bayer Healthcare Pharmaceuticals Inc. | $499 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Mirena Drug, Women's Health | 2019 | |
| 2019-03-21 | Alexion Pharmaceuticals, Inc. | $1,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Kanuma Drug, Immunology | 2019 | |
| 2019-03-15 | W. L. Gore & Associates, Inc. | $917 | Research payment | Cash or cash equivalent | Carotid Stent Device, Devices | GORE Carotid Stent Clinical Study for the treatment of carotid artery stenosis in patients at increased risk for adverse | 2019 |
| 2019-03-14 | MEDELA LLC | $400 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Device, Breastpumps | 2019 | |
| 2019-03-05 | Chiesi USA, Inc. | $500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | CUROSURF Drug, NEONATOLOGY | 2019 | |
| 2019-02-27 | KLS-Martin L.P. | $1,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2019 | ||
| 2019-02-15 | Osiris Therapeutics Inc. | $1,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Stravix Biological, Other Advanced Wound Management | 2019 | |
| 2019-02-14 | GE HEALTHCARE | $500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Device, LIFE CARE SOLUTIONS | 2019 | |
| 2019-02-07 | Incyte Corporation | $1,083 | Research payment | Cash or cash equivalent | A Phase 12 Study of the Safety, Tolerability, and Efficacy of INCB24360 Administered in Combination With Nivolumab in Se | 2019 | |
| 2019-02-07 | Bio-Rad Laboratories, Inc. | $408 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Lyphochek Device, Controls | 2019 | |
| 2019-01-31 | Incyte Corporation | $22 | Research payment | Cash or cash equivalent | A Phase 12 Study of the Safety, Tolerability, and Efficacy of INCB24360 Administered in Combination With Nivolumab in Se | 2019 | |
| 2019-01-31 | Incyte Corporation | $22 | Research payment | Cash or cash equivalent | A Phase 12 Study of the Safety, Tolerability, and Efficacy of INCB24360 Administered in Combination With Nivolumab in Se | 2019 | |
| 2019-01-28 | Eli Lilly and Company | $871 | Research payment | In-kind items and services | A PHASE 1B OPEN-LABEL PHASE 2 RANDOMIZED, DOUBLE-BLINDED STUDY EVALUATING NAB-PACLITAXEL AND GEMCITABINE WITH OR WITHOUT | 2019 | |
| 2019-01-15 | ACELL, INC. | $1,722 | Education | Cash or cash equivalent | 2019 | ||
| 2019-01-08 | Stryker Corporation | $402 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | 2019 | |
| 2019-01-08 | Stryker Corporation | $152 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | 2019 | |
| 2019-01-08 | Stryker Corporation | $39 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | 2019 | |
| 2019-01-08 | Stryker Corporation | $38 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | 2019 | |
| 2019-01-03 | Incyte Corporation | $13,934 | Research payment | Cash or cash equivalent | A Phase 12 Study of the Safety, Tolerability, and Efficacy of INCB24360 Administered in Combination With Nivolumab in Se | 2019 | |
| 2019-01-03 | Incyte Corporation | $6,342 | Research payment | Cash or cash equivalent | A Phase 12 Study of the Safety, Tolerability, and Efficacy of INCB24360 Administered in Combination With Nivolumab in Se | 2019 | |
| 2019-01-03 | Incyte Corporation | $5,133 | Research payment | Cash or cash equivalent | A Phase 12 Study of the Safety, Tolerability, and Efficacy of INCB24360 Administered in Combination With Nivolumab in Se | 2019 | |
| 2019-01-03 | Incyte Corporation | $22 | Research payment | Cash or cash equivalent | A Phase 12 Study of the Safety, Tolerability, and Efficacy of INCB24360 Administered in Combination With Nivolumab in Se | 2019 | |
| 2019-01-03 | Incyte Corporation | $22 | Research payment | Cash or cash equivalent | A Phase 12 Study of the Safety, Tolerability, and Efficacy of INCB24360 Administered in Combination With Nivolumab in Se | 2019 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Sioux Falls, SD, county Minnehaha County, SD, state South Dakota; placed by its city name.
| Measure | Place (city or town) Sioux Falls, SD | County Minnehaha County, SD | State South Dakota |
|---|---|---|---|
| Population B01003 | 201,469 | 203,289 | 907,428 |
| Population, 2020 census P1 | 192,517 | 197,214 | 886,667 |
| Median age B01002 | 35.5 | 36.0 | 38.0 |
| Under 18 B01001 | 24.4% | 25.4% | 24.2% |
| 65 and over B01001 | 14.1% | 13.9% | 18.0% |
| Households B11001 | 85,992 | 84,814 | 365,544 |
| Foreign born B05002 | 8.7% | 7.6% | 4.0% |
| Median household income B19013 | $75,970 | $76,880 | $75,081 |
| Median family income B19113 | $102,134 | $104,994 | $96,562 |
| Per capita income B19301 | $44,604 | $43,062 | $40,550 |
| Poverty rate B17001 | 9.6% | 8.8% | 11.9% |
| Unemployment rate B23025 | 2.5% | 2.5% | 2.9% |
| Civilian labor force B23025 | 116,457 | 116,075 | 475,223 |
| Mean commute (minutes) B08013 | 17.0 | 17.8 | 17.8 |
| Bachelor's degree or higher B15003 | 38.1% | 35.2% | 31.9% |
| Housing units B25001 | 90,271 | 89,418 | 408,584 |
| Owner-occupied B25003 | 59.5% | 63.1% | 68.6% |
| Renters B25003 | 40.5% | 36.9% | 31.4% |
| Median home value B25077 | $292,400 | $287,600 | $257,400 |
| Median gross rent B25064 | $1,035 | $978 | $946 |
| White, not Hispanic B03002 | 78.0% | 78.6% | 79.8% |
| Black B03002 | 6.6% | 6.3% | 2.1% |
| Hispanic or Latino B03002 | 6.5% | 6.6% | 4.8% |
| Asian B03002 | 2.1% | 1.6% | 1.4% |
| American Indian and Alaska Native B03002 | 1.7% | 1.8% | 7.1% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Sioux Falls, SD.
Comments